The Cancer Genome Atlas Pan-Cancer analysis project - PubMed (original) (raw)
. 2013 Oct;45(10):1113-20.
doi: 10.1038/ng.2764.
Collaborators, Affiliations
- PMID: 24071849
- PMCID: PMC3919969
- DOI: 10.1038/ng.2764
The Cancer Genome Atlas Pan-Cancer analysis project
Cancer Genome Atlas Research Network et al. Nat Genet. 2013 Oct.
Abstract
The Cancer Genome Atlas (TCGA) Research Network has profiled and analyzed large numbers of human tumors to discover molecular aberrations at the DNA, RNA, protein and epigenetic levels. The resulting rich data provide a major opportunity to develop an integrated picture of commonalities, differences and emergent themes across tumor lineages. The Pan-Cancer initiative compares the first 12 tumor types profiled by TCGA. Analysis of the molecular aberrations and their functional roles across tumor types will teach us how to extend therapies effective in one cancer type to others with a similar genomic profile.
Figures
Figure 1. Integrated data set for the comparison and contrast of multiple tumour types
The Pan-Cancer project assembled data from thousands of patients with primary tumours occurring in different sites of the body covering twelve tumour types (upper left panel) including glioblastoma multiform (GBM), lymphoblastic acute myeloid leukemia (LAML), head and neck squamous carcinoma (HNSC), lung adenocarcinoma (LUAD), lung squamous carcinoma (LUSC), breast carcinoma (BRCA), kidney renal clear cell carcinoma (KIRC), ovarian carcinoma (OV), bladder carcinoma (BLCA), colon adenocarcinoma (COAD), uterine cervical and endometrial carcinoma (UCEC), and rectal adenocarcinoma (READ). Six platforms of omics characterizations were performed creating a “data stack” (upper right panel) in which data elements across the platforms are linked by the fact that tissue material from the same samples were assayed, thus maximizing the potential of integrative analysis. Use of the data enables the identification of general trends including common pathways (lower panel) revealing master regulatory hubs activated (red) or deactivated (blue) across different tissue types.
Figure 2. Data coordination for the Pan-Cancer TCGA project
Data were collected by the biospecimen collection resource (BCR) from 12 different tumour types, characterized on six major platforms by the genome characterization and sequencing centers (GCC/GSC). Datasets are deposited into the TCGA data coordination center (DCC) from which it is then distributed to the Broad Institute's Firehose and Memorial Sloan Kettering Cancer Center's cBioPortal for various automated processing pipelines. Analysis working groups (AWG) conduct focused analyses on individual tumour types. Results from the DCC, Firehose, and AWGs were collected and stored in Sage Bionetworks’ Synapse system to create a “data freeze.” Genome data analysis centers (GDACs) accessed and deposited both data and results through Synapse to coordinate distributed analyses.
Similar articles
- [Cancer Genome Atlas Pan-cancer Analysis Project].
Zhang K, Wang H. Zhang K, et al. Zhongguo Fei Ai Za Zhi. 2015 Apr;18(4):219-23. doi: 10.3779/j.issn.1009-3419.2015.04.02. Zhongguo Fei Ai Za Zhi. 2015. PMID: 25936886 Free PMC article. Review. Chinese. - Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases.
Chen F, Zhang Y, Gibbons DL, Deneen B, Kwiatkowski DJ, Ittmann M, Creighton CJ. Chen F, et al. Clin Cancer Res. 2018 May 1;24(9):2182-2193. doi: 10.1158/1078-0432.CCR-17-3378. Epub 2018 Feb 9. Clin Cancer Res. 2018. PMID: 29440175 Free PMC article. - A pan-cancer proteomic perspective on The Cancer Genome Atlas.
Akbani R, Ng PK, Werner HM, Shahmoradgoli M, Zhang F, Ju Z, Liu W, Yang JY, Yoshihara K, Li J, Ling S, Seviour EG, Ram PT, Minna JD, Diao L, Tong P, Heymach JV, Hill SM, Dondelinger F, Städler N, Byers LA, Meric-Bernstam F, Weinstein JN, Broom BM, Verhaak RG, Liang H, Mukherjee S, Lu Y, Mills GB. Akbani R, et al. Nat Commun. 2014 May 29;5:3887. doi: 10.1038/ncomms4887. Nat Commun. 2014. PMID: 24871328 Free PMC article. - Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas.
Chen F, Zhang Y, Varambally S, Creighton CJ. Chen F, et al. Mol Cancer Res. 2019 Feb;17(2):476-487. doi: 10.1158/1541-7786.MCR-18-0601. Epub 2018 Nov 6. Mol Cancer Res. 2019. PMID: 30401717 Free PMC article. - The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.
Tomczak K, Czerwińska P, Wiznerowicz M. Tomczak K, et al. Contemp Oncol (Pozn). 2015;19(1A):A68-77. doi: 10.5114/wo.2014.47136. Contemp Oncol (Pozn). 2015. PMID: 25691825 Free PMC article. Review.
Cited by
- Scalable, compressed phenotypic screening using pooled perturbations.
Liu N, Kattan WE, Mead BE, Kummerlowe C, Cheng T, Ingabire S, Cheah JH, Soule CK, Vrcic A, McIninch JK, Triana S, Guzman M, Dao TT, Peters JM, Lowder KE, Crawford L, Amini AP, Blainey PC, Hahn WC, Cleary B, Bryson B, Winter PS, Raghavan S, Shalek AK. Liu N, et al. Nat Biotechnol. 2024 Oct 7. doi: 10.1038/s41587-024-02403-z. Online ahead of print. Nat Biotechnol. 2024. PMID: 39375446 - Multi-omics analysis identifies BCAT2 as a potential pan-cancer biomarker for tumor progression and immune microenvironment modulation.
Cao Q, Fan J, Zou J, Wang W. Cao Q, et al. Sci Rep. 2024 Oct 8;14(1):23371. doi: 10.1038/s41598-024-74441-1. Sci Rep. 2024. PMID: 39375392 Free PMC article. - Melanoma-specific mutation hotspots in distal, non-coding, promoter-interacting regions implicate novel candidate driver genes.
Pudjihartono M, Pudjihartono N, O'Sullivan JM, Schierding W. Pudjihartono M, et al. Br J Cancer. 2024 Oct 4. doi: 10.1038/s41416-024-02870-w. Online ahead of print. Br J Cancer. 2024. PMID: 39367275 - Big Data for Geriatric Oncology Research.
Duchesneau ED, Klepin HD, Hanchate AD, Lin MY, Bluethmann SM. Duchesneau ED, et al. N C Med J. 2024;85(1):20-24. doi: 10.18043/001c.91420. Epub 2024 Jan 9. N C Med J. 2024. PMID: 39359617 - Deep learning-based approaches for multi-omics data integration and analysis.
Ballard JL, Wang Z, Li W, Shen L, Long Q. Ballard JL, et al. BioData Min. 2024 Oct 2;17(1):38. doi: 10.1186/s13040-024-00391-z. BioData Min. 2024. PMID: 39358793 Free PMC article. Review.
References
- Soda M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448:561–566. - PubMed
- Parada LF, Tabin CJ, Shih C, Weinberg RA. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature. 1982;297:474–478. - PubMed
- Payne GS, Bishop JM, Varmus HE. Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas. Nature. 1982;295:209–214. - PubMed
- Baker SJ, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989;244:217–221. - PubMed
- Tomlins SA, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644–648. doi:10.1126/science.1117679. - PubMed
Publication types
MeSH terms
Grants and funding
- P30 CA016672/CA/NCI NIH HHS/United States
- U24 CA143882/CA/NCI NIH HHS/United States
- U24 CA143835/CA/NCI NIH HHS/United States
- K08 CA137153/CA/NCI NIH HHS/United States
- R01 HG005690/HG/NHGRI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- U24 CA143840/CA/NCI NIH HHS/United States
- U24 CA143858/CA/NCI NIH HHS/United States
- R01 CA180778/CA/NCI NIH HHS/United States
- U24 CA143883/CA/NCI NIH HHS/United States
- P50 CA098258/CA/NCI NIH HHS/United States
- U01 CA168394/CA/NCI NIH HHS/United States
- P01 CA101937/CA/NCI NIH HHS/United States
- P50 CA083639/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources